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Abstract 
Objective: There is no widely accepted standard definition for Ventilator Associated Pneumonia 
(VAP). The reliability of the current definitions in use remains controversial. Our objective was 
to assess the reliability of six commonly used VAP definitions: The Loose, The Rigorous, The 
Modified Clinical Pulmonary Infection Score (CPIS), The Canadian Critical Care Trials Group 
(CCCTG), The International Sepsis Forum Consensus (ISFC) and The Center for Disease 
Control and Prevention (CDC). 
Design: We examined the electronic health records of all the consecutively admitted adult 
patients at our institution who received invasive mechanical ventilation (IMV) for ≥ 48 hours, 
from January 2006 through December 2006.Patients were excluded if they developed pneumonia 
within the first 48 hours or if they had a tracheostomy before IMV. Two expert intensivists 
independently reviewed the following data for each patient: indications and duration of IMV, 
vital signs, oxygen requirements, the frequency of respiratory suctioning, amount, color and 
consistency of secretion, ventilator settings, leukocyte count, microbiologic and radiographic 
data. Interreviewer reliability in diagnosing VAP independently were compared using Cohen’s-
Kappa statistics. 
Results:  A total of 115 patients met the initial inclusion criteria of which 47 patients were 
excluded (40 had pneumonia on presentation, 6 developed pneumonia within 48 hours and 1 had 
a tracheostomy on admission). The inter-reviewer agreement Kappa for the Loose, the Rigorous, 
CPIS, CCCTG, ISFC and CDC definitions for VAP were 0.22, 0.49, 0.33, 0.41, 0.38 and 0.68 
respectively. 
Conclusion: The CDC definition of VAP proved to be statistically more reliable than other 
tested definitions of VAP, as demonstrated by the lowest interrater variability between two 
independent reviewers. 















Ventilator-associated pneumonia (VAP) is the most common nosocomial infection in 
mechanically ventilated intensive care unit (ICU) patients.1  The data collected by National 
Healthcare Safety Network (NHSN) from 2006 and 2008 revealed an incidence of VAP that 
ranged from approximately 3 per 1000 ventilator days in medical/surgical teaching ICUs to 
almost 11 per 1000 ventilator days in burn units.2  Using the same definition, subsequent data 
from 2011 demonstrated VAP rates of 1.1 per 1000 ventilator days in medical/surgical teaching 
ICUs and approximately 5 per 1000 ventilator days in burn units.3  Various institutions have 
traditionally used the CDC definition to identify VAPs for reporting nosocomial infections to the 
NHSN, however, several other definitions have been used for both clinical and research 
applications. There exists no consensus for a gold standard definition for VAP and the reliability 
of currently used definitions remains in question.4-7  There are six definitions that are commonly 
used for VAP: the Loose,8 the Rigorous,8 the Modified Clinical Pulmonary Infection Score 
(CPIS),8,9  the Canadian Critical Care Trials Group (CCCTG),10  the International Sepsis Forum 
Consensus (ISFC)11 and the Center for Disease Control and Prevention (CDC).12   Despite the 
abundance of literature on VAP, there is a paucity of studies that compare the difference in VAP 
incidence using different clinical definitions of VAP in the same patient population.7,13   
 
Therefore, we conducted a population-based study to test the interrater variability of six 




We conducted a retrospective electronic medical record (EMR) chart review of all the adult 
patients (≥ 18 years) from Olmsted County who were admitted to the Intensive Care Units (ICU) 
at our center, and required invasive mechanical ventilation (IMV) for > 48 hours, from January 
1, 2006 through December 31, 2006. The Institutional Review Board (IRB) approved the study 
(#10-006656). After receiving the IRB approval, we identified patients who gave consent for the 
use of their EMR for research, and met the inclusion criteria. Patients who had pneumonia on 
presentation, developed pneumonia within 48 hours from admission or had a tracheostomy upon 
admission were excluded. Two expert intensivists (Reviewers A and B) independently screened 
the EMRs of all the included patients to make a diagnosis of VAP (figure 1). The reviewers 
discussed the different definitions at the beginning of the study to assure mutual understanding of 
the definitions. The reviewers screened patients’ records for changes in temperature, change in 
oxygen requirements, change in WBC count, and sputum cultures. If any change was detected, 
the reviewers would subject the case to the various definitions of VAP to determine which 
definitions applied. During the review process there was no direct discussion between the 
reviewers pertinent to any case in the study. 
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Figure 1. The flowchart showing the method for diagnosing ventilator associated pneumonia 
patients. 
 
Footnote: ICU=intensive care unit, MV=mechanical ventilation; VAP= ventilator associated pneumonia 
In addition to the clinical, microbiological, radiographic data, and laboratory reports, patients’ 
demographics, baseline conditions, comorbidities, severity of illness (Acute Physiology and 
Chronic Health Evaluation [APACHE III] score, organ dysfunction (Sequential Organ Failure 
Assessment [SOFA] score, reasons for MV, intubation type, infection severity (sepsis, severe 
sepsis or septic shock),14 modified CPIS score,15 documented witnessed aspiration, prescription 
of appropriate initial antimicrobial treatment, and compliance with Institute of Health Care 
Improvement ventilator bundle were abstracted from the EMR. Other important variables that 
were abstracted included date of admission, admission diagnosis, date and location of intubation, 
indication for IMV, duration of IMV, vital signs, oxygen requirements, frequency of respiratory 
suctioning, amount, color and consistency of secretion, ventilator settings, leukocytes, potential 
sources of infection, date of extubation and date of dismissal or expiration and nutritional status. 
Whenever the constellation of clinical, laboratory, microbiologic and radiographic data 
suggested the development of pneumonia the reviewers independently would apply the six 
definitions to determine whether or not a given patient met the criteria for one or more definition. 
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A patient identified as having VAP by any definition is considered as a positive case of VAP. 
The detailed explanation about the six VAP definitions is given in the online supplement. 
Statistical analysis 
 
The categorical data was summarized as counts and percentage, whereas, continuous data was 
summarized as median (interquartile range [IQR]). Student’s-t test and Mann-Whitney U test 
were used to compare the continuous variables with normal distribution and skewed distribution, 
respectively, whereas Chi-square and Fisher’s exact test were used to compare the categorical 
variables, depending on the size of the variable in the contingency table. Cohen’s kappa statistics 
were used to estimate the inter-reviewer variability for each one of the six definitions for VAP 
between the two reviewers.16  A kappa value of <0.2 was considered to reflect poor inter-
reviewer agreement, 0.21-0.40 was considered fair, 0.41-0.60 was considered moderate, 0.61-
0.80 was considered good and >0.80 was considered excellent.16  For this study, we defined 
“reliability” as the VAP definition with the lowest level of interrater variability between two 
independent observers. It is important to know that reliability does not imply “accuracy” of VAP 
diagnosis (whether a patient has or does not have VAP) – only that observers using a particular 
definition arrived at the same diagnostic conclusion. All of the analyses were performed using 





During the study, 115 patients met the initial inclusion criteria. After thorough independent 
revision by both reviewers, the reviewers excluded 47 patients (40 had pneumonia on 
presentation, 6 developed pneumonia within 48 hours and 1 had a tracheostomy on admission) 











Nusair, et al.: Ventilator associated Pneumonia definitions
Published by Marshall University's Joan C. Edwards School of Medicine, 2015
Figure 2. The interrater variability of different ventilator associated pneumonia definitions. 
CDC= The Center for Disease Control and Prevention, CPIS= the modified Clinical Pulmonary Infection Score, 
MV=mechanical ventilation. 
The table shows the differences in baseline characteristics, causes for mechanical ventilation, 
comorbidities, and outcomes between the patients with VAP (all the possible cases identified by 
both the authors) and without VAP. There was no difference in the baseline characteristics and 
severity of illness between the VAP and non-VAP patients. Most of the patients with VAP were 
admitted in the surgical ICU (81%) as compared to the patients without VAP (55%), p=0.06. The 
most common antecedent documented conditions in VAP patients were coma (43%), 
postoperative state (19%), cardiogenic pulmonary edema (10%) and acute respiratory distress 
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Table: Differences in baseline characteristics, causes, comorbidities, and outcomes between 
ventilator associated pneumonia (VAP) and non-VAP patientsa 
Demographics VAP (n=21) Non-VAP (n=47) P-value 
Age (y) 67 (49-81) 67 (46-77)  0.87 
Sex: male  13 (62) 28 (60) 0.86 
Race: Caucasian 17 (81) 42 (89)            0.44 
Body mass index 27 (24-32) 24 (20-32) 0.67 
APACHE III score 76 (68-98) 76 (53-94) 0.91 
SOFA score on day one 7 (5-9) 6 (4-8) 0.27 
ICU type: Medical 4 (19) 21 (45) 0.06 
Surgical 17 (81) 26 (55)   
Cause for mechanical 
ventilation 
    
Cardiogenic pulmonary edema 2 (10) 3 (6) 0.64 
Acute respiratory distress 
syndrome 
2 (10) 5 (11) 0.99 
Trauma 1 (5) 4 (9) 0.99 
Coma 9 (43) 8 (17) 0.02 
Cardiac arrest 1 (5) 4 (9) 0.99 
Post-Surgery 4 (19) 8 (17) 0.99 
COPD exacerbation/acute 
asthma 
1 (5) 6 (13) 0.42 
Comorbid conditions     
Pulmonary diseases 4 (19)  15 (32) 0.38 
Congestive heart failure 5 (24) 7 (15) 0.37 
Diabetes 8 (38) 11 (23) 0.21 
Moderate to severe renal 
disease 
3 (14) 6 (13) 0.99 
Malignancy 5 (24) 10 (21) 0.82 
Lymphoma     
Outcomes     
Reintubation 6 (29) 3 (6) 0.02 
ICU length of stay (d) 13.6 (10.1-15.7) 6.6  (5.1-8.8) <0.01 
Hospital length of stay (d) 20.1 (15.8-27.9) 12.3 (8.9-18.6) 0.3 
IMV days 7.2 (1.6-11.3) 3.5 (2.1-5.4) 0.01 
Hospital mortality 6 (29) 10 (21) 0.51 
aData are presented as No. (percentage) or median (interquartile range). APACHE = Acute Physiology and Chronic 
Health Evaluation; COPD = chronic obstructive pulmonary diseases; ICU = Intensive Care Unit; IMV= Invasive 
mechanical ventilation; SOFA= Sequential Organ Failure Assessment score 
 
VAP patients were re-intubated more often than non-VAP patients (29% vs. 6%, respectively) 
p=0.02.  There was no difference in the mortality at hospital discharge among the VAP and non-
VAP patients (p=0.51), however, VAP patients were mechanically ventilated for a longer 
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For cases that were suspected to have developed VAP, reviewer A determined that 10, 3, 6, 13, 
14 and 8 cases met the Loose, the Rigorous, CPIS, CCCTG, ISFC and CDC Definition, 
respectively. Whereas, the reviewer B determined that 5, 1, 5, 5, 5 and 5 met The Loose, The 
Rigorous, CPIS, CCCTG, ISFC and CDC Definition, respectively. The kappa value for the 
Loose, the Rigorous, CPIS, CCCTG, ISFC and CDC definitions between the two reviewers was 




We evaluated the interrater/reviewer variability of six common definitions used to identify VAP 
in the ICU. We observed large inter-reviewer variability when diagnosing VAP from medical 
record review. Out of the six definitions of VAP, only the CDC definition had good interrater 
variability between the two reviewers. The Rigorous and CCCTG definitions were moderately 
reliable, whereas, the Loose, CPIS and ISFC definitions were only fairly reliable in diagnosing 
VAP. To the best of our knowledge, this is the first study that measured the interrater variability 
of VAP definitions.  
 
VAP definitions rely on integrating clinical findings, radiographic and microbiologic data to 
establish the diagnosis. The clinical findings can be in part subjective, and hence, vulnerable to 
variability in the way they are documented and interpreted. Additionally, chest radiographic 
changes can be due to pathological processes other than, but resembling pneumonia ranging from 
lung contusion in trauma patients to pulmonary edema and pleural effusions in heart failure 
patients. The matter is complicated further by the fact that some of the radiographic changes can 
persist for weeks, potentially masking new processes. Previous studies support the finding that 
interpretation of chest radiographs can vary between clinicians.17,18  Treating physicians and 
radiologists may also interpret chest radiographs differently.18,19  Furthermore, microbiologic 
data can be difficult to interpret, as mechanically ventilated patients’ airways invariably become 
colonized with hospital flora. ICU patients commonly receive prophylactic, empiric or 
therapeutic antimicrobials, which can result in change in patients’ flora and select out for 
resistant opportunistic and pathogenic bacteria. They can also suppress bacterial growth and 
decrease the yield of cultures. All of these issues have to be taken in consideration when 
processing microbiologic information in this patient population. Some authorities have proposed 
that respiratory cultures obtained invasively via bronchoscopy should be the gold standard in 
making the diagnosis of VAP. This notion is impractical to apply in clinical practice. The 
invasive nature of the procedure, the time it takes to perform, and the cost of procedure, are 
certainly barriers to its utility in investigating VAP.  Furthermore, the level of training and 
expertise of the reviewer can affect the processing of data necessary to diagnose VAP. In one 
study looking at these two variables, inter-observer agreement was moderate at best when 
applying the CDC definition.20  Relying on objective data to diagnose VAP may be a better way 
to standardize reviewers and institutions reporting for epidemiologic purposes, however, from a 
clinical perspective it may be difficult, due to the need for assessing various parameters to 
diagnose VAP.  
 
Several governing bodies are interested in institutional VAP rates. The mandate for public 
reporting is on the horizon. The way Centers for Medicare and Medicaid Service will consider 
VAP rates in the reimbursement process remains unclear. In addition, it remains unclear if these 
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governing bodies will use epidemiologic criteria, i.e. NHSN reports, or administrative data, i.e. 
ICD-9 coding, to compare different institutions in quality of care performance measures. The 
major concern with the use of administrative databases to measure VAP incidence rates is the 
underreporting of VAP cases in these databases,19  which falsely lowers the incidence of VAP in 
the community. For this reason, the CDC introduced new possible/probable VAP definitions that 
address various events that could affect patients while on mechanical ventilation.21  The new 
definition is rather a group of definitions that are meant to distinguish ventilator associated 
events that are not necessarily infectious in nature from those that are infectious in nature. Those 
that are infectious in nature are then further classified into possible and probable VAP. In the 
most simple way to understand the new definitions: for a patient to be considered to have a 
possible or probable VAP, he or she would have to have at least two days of invasive mechanical 
ventilation with stable fraction of inspired oxygen (FiO2) and positive end-expiratory pressure 
(PEEP) for at least two days. He or she would have to then develop a change in either FiO2 or 
PEEP (>20% increase or >3 cm H2O respectively) and the change be sustained for at least two 
days, and accompanied by evidence of inflammatory response ( leukocytosis and/or fever) or 
clinical suspicion of infectious process for which antibiotics are initiated and continued along 
with purulent respiratory secretions and/or positive respiratory secretions cultures for a bacterial 
pathogen. The new definition focuses on changes in oxygenation as a trigger to investigate a 
possible VAP. It aims to distinguish between infectious and non-infectious complications of 
mechanical ventilation, and acknowledges the fact that VAP diagnosis is not always clear-cut 
and can be possible or probable. The new definitions are expected to be more objective and less 
susceptible to individual variation in interpretation, but will need to be studied further. At the 
time we conducted our study, the new CDC definitions were not available.  
 
Our study has both strengths and weaknesses. Major strengths are 1) the population-based nature 
of the study, designed specifically to study the interrater variability of the VAP definitions 
eliminates the referral and sampling biases seen in the observational studies; 2) we used a 
comprehensive approach to diagnose the VAP cases and used a standardized operating protocol 
throughout the study, which enhanced the quality of our study. This study also has limitations. 
Only two observers participated and there was a wide variability between each observer 
collectively using any definition of VAP. It is retrospective which may lend to confounding and 
unmeasured bias. To account for these biases we used quality measures like a standardized 
protocol for data gathering, diagnosis of the VAP and data extraction. Although the study was 
conducted at a single center, which raises some concerns regarding the generalizability of the 
results, Mayo Clinic is the only center providing critical care services in the Olmsted County.22  
Furthermore, findings from the Olmsted County population have shown to be generalizable to 
the Upper Midwest population and provide invaluable information regarding various diseases, 
which are consistent with the national data.23,24   
 
CONCLUSION:  
The CDC definition of VAP proved to be statistically more reliable than other tested definitions 
of VAP as demonstrated by the lowest interrater variability between two independent reviewers.   
 
78
Nusair, et al.: Ventilator associated Pneumonia definitions
Published by Marshall University's Joan C. Edwards School of Medicine, 2015
Supplement 
The six definitions used in this study: 
1. Loose definition: chest x-ray infiltrate (unilobar, unilateral, or bilateral) with 2 of the 
following 3 findings: temperature, >38°C or <35.5°C; white blood cell count, >10,000/μL or 
<4000/μL; or purulent respiratory secretions.  
2. Rigorous definition: chest x-ray infiltrate (unilobar, unilateral, or bilateral) with all of the 
following 3 findings: temperature, >38°C or <35.5°C; white blood cell count, >10,000/μL or 
<4000/μL; or purulent respiratory secretions.  
3. The modified clinical pulmonary infection score (CPIS) ≥6. 
The modified clinical pulmonary infection score 
Criterion Range Score 
Temperature, ≥36.5 and ≤38.4 0 
 ≥38.5 and ≤38.9 1 
 ≥39.0 and ≤36.0 2 
Blood leukocyte, mm3 ≥4,000 and ≤11,000 0 
 <4,000 or >11,000 1 
 +band forms ≥500 2 
Tracheal secretions Absence 0 
 Presence and non-purulent (color: white or 
light-yellow) 
1 
 Presence and purulent (color: yellow, green or 
brown) 
2 
Oxygenation, PaO2/FiO2 >240 or ARDS 0 
 ≤240 and no evidence of ARDS 2 
Pulmonary radiography No infiltrate 0 
 Diffused (or patchy) infiltrate 1 
 Localized infiltrate 2 
Culture of tracheal aspirate 
(semi-quantitative:0-1-2 or 
3+) 
Pathogenic bacteria cultured ≤1+ or no growth 0 
 Pathogenic bacteria cultured >1+ 1 
 +same pathogenic bacteria seen on the Gram 
stain >1+ 
2 
Definition of abbreviations: ARDS = acute respiratory distress syndrome; CHF = congestive 
heart failure; PaO2/FIO2 = ratio of arterial oxygen pressure to fraction of inspired oxygen. 
4. The Canadian Critical Care Trials Group classification 
A. Definite bacterial pneumonia: at least one of the following three criteria was fulfilled:  
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1. Positive result of pleural fluid culture 
2. Rapid cavitation of the lung infiltrate as determined by computed tomography or 
3. Histopathologic demonstration of pneumonia (consolidation with intense 
polymorphonuclear leukocyte accumulation in bronchioles and adjacent alveoli 
involving several adjacent low-power microscopic, with or without tissue 
necrosis) during biopsy or autopsy. 
B. Probable bacterial pneumonia: if none of the above criteria were met yet patient had 
cultures of specimens obtained using a bronchoalveolar lavage which grew at least one 
organism in significant concentration (>104 cfu/ml). 
C. Possible pneumonia: if none of the above criteria were met yet patient's chest 
radiograph, sputum culture, temperature, white blood cell count and clinical course were 
consistent with pneumonia. 
D. No pneumonia- if in the opinion of the study investigator, the patient’s course was not 
compatible with pneumonia. 
5. The International Sepsis Forum Consensus definition  
1. Microbiologically confirmed: if fulfilled one of the following criteria 
a. The patient must have a new or progressive radiographic infiltrate, along with a 
high clinical suspicion of pneumonia (or a CPIS of ≥6, using a Gram stain of a 
lower respiratory tract sample) plus a definite cause established by the recovery of 
a probable etiologic agent from a) an uncontaminated specimen (blood, pleural 
fluid, transtracheal aspirate, or transthoracic aspirate); 
b. The recovery from respiratory secretions of a likely pathogen that does not 
colonize the upper airways (e.g., Mycobacterium tuberculosis, Legionella species, 
influenza virus, or Pneumocystis jiroveci (carinii); 
c. Recovery of a likely/possible respiratory pathogen in high concentrations using 
quantitative cultures of a lower respiratory tract sample (endotracheal aspirate, 
BAL, or protected specimen brush) 
d. Positive serology. 
2. Probable: The patient must have a new or progressive radiographic infiltrate along with 
a high clinical suspicion of pneumonia (or a CPIS of ≥6, using a Gram stain of a lower 
respiratory tract sample) plus detection (by staining or culture) of a likely pulmonary 
pathogen in respiratory secretions (expectorated sputum, endotracheal or bronchoscopic 
aspirate, or quantitatively cultured bronchoscopic BAL fluid or brush catheter specimen), 
but in concentrations below the diagnostic threshold, or the presence of a negative lower 
respiratory tract culture if collected within 72 hours after starting a new antibiotic 
regimen. 
3. Possible: Abnormal chest radiograph of uncertain cause, in a patient with a low or 
moderate clinical suspicion of pneumonia, but with microbiological or serological 
evidence of definite or probable pneumonia (as defined above). 
6. The Center for Disease Control and Prevention (CDC). 
Clinical diagnosis of VAP was defined as the presence of new or progressive and persistent 
infiltrates, or consolidation, or cavitations on the chest radiograph, and at least 1 of the 
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following: fever >38°C with no other recognized cause, leukocytosis (≥12.0 × 109/L) or 
leukopenia (<4.0 × 109/L), or altered mental status with no other cause in ≥70 years old; and at 
least 2 of the following: new onset of purulent sputum or change in character of sputum or 
increased respiratory secretions or increased suctioning requirements, new onset or worsening 
cough or dyspnea or tachypnea, rales or bronchial breath sound, worsening gas. 
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